Miguel Arcinas is Capstan’s Vice President of Corporate Development. Miguel has over 14 years of multi-disciplinary experience in biotech corporate strategy, business development, investor relations, and clinical operations. Prior to Capstan, Miguel served as Vice President of Corporate Development and Investor Relations at Silverback Therapeutics, contributing to the company’s Series C raise, IPO, and merger activities. He has held corporate development and operational roles of increasing responsibility at various biopharma companies including Synthorx, where he contributed to the company’s acquisition by Sanofi, Acadia Pharma, and Ignyta.
Current role
VP of Corporate Development at Acacia Communications
VP of Corporate Development at Cytocom
VP of Corporate Development at StrideBio
VP of Corporate Development at Chicagoland Chamber of Commerce
VP of Corporate Development at Service Logic